|Trade names||(none, active metabolite of Rilmazafone)|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|3D model (JSmol)|
Rilmazolam, is a benzodiazepine derivative which acts as a sedative and hypnotic drug, and the active metabolite of the drug Rilmazafone. It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication in Japan.
- Koike M, Norikura R, Sugeno K (March 1986). "Intestinal activation of a new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in rats". Journal of Pharmacobio-Dynamics. 9 (3): 315–20. doi:10.1248/bpb1978.9.315. PMID 3454653.